Ospedale San Vincenzo Taormina
- Address
- lock Available on a paid plan
Ospedale San Vincenzo Taormina - Oncology Research Center
Ospedale San Vincenzo Taormina is actively engaged in advanced oncological research, focusing on innovative therapeutic strategies for solid tumors. The center participates in multi-center trials investigating novel approaches to improve treatment outcomes in patients with challenging malignancies.
- Neoadjuvant therapy optimization for locally advanced rectal cancer using aspirin and metformin combinations
- Immunotherapy trials for resectable melanoma with PD-1 and LAG-3 checkpoint inhibitors
- Pathological response assessment in peri-operative oncology treatments
The center's research portfolio demonstrates expertise in evaluating combination treatment strategies for gastrointestinal and skin cancers. Through participation in intergroup studies, including the NeoAspMet trial for stage II/III rectal cancer and trials investigating dual checkpoint inhibition with fianlimab and cemiplimab in resectable melanoma, the institution contributes to advancing personalized cancer care and exploring the potential of repurposed medications alongside standard neoadjuvant chemoradiotherapy protocols.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ospedale San Vincenzo Taormina
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2 Peri-operative Trial of Fianlimab and Cemiplimab Compared with Anti-PD1 Alone in Patients with Resectable Stage III and IV Melanoma | Regeneron Pharmaceuticals Inc. | Phase II | Not Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Capecitabine | 1 | Unknown | 2020-10-22 | 2020-10-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.